Undervalued Stocks Based On Cash Flows

결과

37

13개 신규

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

37개 기업

기업최종 가격7일 수익률1년 수익률시가총액애널리스트 목표가가치평가성장배당 수익률산업
6990
HK$524.50-1.6%15.5%HK$125.4bHK$614.54711.244.0%n/aPharmaceuticals & Biotech
9676
신규
HK$4.66-4.0%-53.0%HK$4.9bHK$18.509.036.9%8.0%Food, Beverage & Tobacco
2507
신규
HK$46.800.7%-9.2%HK$17.1bHK$63.2413.514.0%2.0%Capital Goods
6055
신규
HK$24.743.7%-38.1%HK$17.1bHK$30.2519.015.9%2.1%Retail
1585
신규
HK$9.47-5.2%-30.5%HK$28.9bHK$14.2310.116.3%5.6%Automobiles
2145
HK$23.30-3.9%-74.6%HK$9.3bHK$74.357.215.7%6.3%Household
2190
신규
HK$21.9411.4%-1.6%HK$7.3bHK$31.1320.527.3%1.2%Healthcare
1318
HK$53.405.6%-43.2%HK$26.2bHK$98.5518.617.1%2.2%Household
1521
신규
HK$1.21-3.2%-11.7%HK$2.5bHK$0.9746.125.0%n/aPharmaceuticals & Biotech
2252
HK$22.92-4.2%17.8%HK$23.6bHK$36.1736.890.9%n/aHealthcare
1364
HK$25.201.4%15.8%HK$59.9bHK$31.3416.816.8%2.0%Consumer Services
2586
HK$4.17-10.1%-63.4%HK$3.6bHK$10.0017.837.7%n/aSoftware
3696
HK$47.026.4%n/aHK$27.1bHK$80.6225.6121.7%n/aPharmaceuticals & Biotech
2235
HK$7.200.6%-3.3%HK$3.0bHK$11.8331.036.9%n/aHealthcare
9658
HK$10.34-7.7%-31.0%HK$6.7bHK$14.4530.030.5%n/aConsumer Services
2419
신규
HK$53.90-0.09%-40.1%HK$20.9bHK$83.510.899.7%0%Food, Beverage & Tobacco
1357
HK$4.472.1%-61.5%HK$20.3bHK$8.6923.830.2%2.2%Media
1866
HK$10.3610.2%39.8%HK$15.0bHK$12.9313.825.4%3.6%Materials
2315
HK$60.20-1.5%188.6%HK$54.4bHK$62.0379.441.0%n/aPharmaceuticals & Biotech
317
신규
HK$12.505.1%-22.4%HK$32.5bn/a11.549.2%2.5%Capital Goods
1801
HK$107.606.3%18.7%HK$187.3bHK$127.88130.434.1%n/aPharmaceuticals & Biotech
9926
HK$101.207.8%-33.5%HK$93.2bHK$165.7026.246.0%n/aPharmaceuticals & Biotech
2268
HK$75.507.5%41.0%HK$95.6bHK$90.8952.829.1%n/aPharmaceuticals & Biotech
6656
HK$366.0014.2%n/aHK$91.1bHK$513.7317.226.2%0.7%Capital Goods
Page 1 of 2